Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie L Leitner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|July 1, 2022
PRO-ACTive sharing of clinical dataNeta Zach, Melanie L Leitner
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Experimental Neurology|January 5, 2005
Expression and function of GDNF family ligands and receptors in the carotid bodyMelanie L Leitner, Leo H Wang, Patricia A Osborne, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Annals of Clinical and Translational Neurology|December 27, 2019
Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trialsMelanie L Leitner, Kush Kapur, Basil T Darras, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Infrastructure resources for clinical research in amyotrophic lateral sclerosisAlexander V Sherman, Amelie K Gubitz, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Biotechnology|November 3, 2014
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progressionRobert Küffner, Neta Zach, Raquel Norel, et al.
Scientific Reports|January 26, 2019
Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approachRobert Kueffner, Neta Zach, Maya Bronfeld, et al.
JAMA|March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, Jeremy M Shefner, Björn Oskarsson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|July 1, 2022
PRO-ACTive sharing of clinical dataNeta Zach, Melanie L Leitner
Neurology|July 8, 2016
Quantitative strength testing in ALS clinical trialsJeremy M Shefner, Dawei Liu, Melanie L Leitner, et al.
Experimental Neurology|January 5, 2005
Expression and function of GDNF family ligands and receptors in the carotid bodyMelanie L Leitner, Leo H Wang, Patricia A Osborne, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2015
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Neta Zach, David L Ennist, Albert A Taylor, et al.
Annals of Clinical and Translational Neurology|December 27, 2019
Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trialsMelanie L Leitner, Kush Kapur, Basil T Darras, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Infrastructure resources for clinical research in amyotrophic lateral sclerosisAlexander V Sherman, Amelie K Gubitz, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Biotechnology|November 3, 2014
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progressionRobert Küffner, Neta Zach, Raquel Norel, et al.
Scientific Reports|January 26, 2019
Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approachRobert Kueffner, Neta Zach, Maya Bronfeld, et al.
JAMA|March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, Jeremy M Shefner, Björn Oskarsson, et al.
Pageof 1